|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|
| Cash flows from (used in) operating activities: | ||||
| Net (loss) income | ||||
| Adjustments to reconcile net income to net cash from operating activities: | ||||
| Accretion of asset retirement obligations | ||||
| Depreciation, depletion, and amortization | ||||
| Amortization of debt issuance costs | ||||
| Stock-based compensation | ||||
| (Gain)/loss on disposal of assets | ||||
| Other income - gain on insurance recoveries | ||||
| Deferred income taxes | ||||
| Changes in operating assets and liabilities: | ||||
| Accounts receivable | ||||
| Prepaid expenses and other current assets | ||||
| Inventories | ||||
| Other assets and liabilities | ||||
| Accounts payable | ||||
| Accrued liabilities | ||||
| Net cash from operating activities | ||||
| Cash flows from (used in) investing activities: | ||||
| Capital expenditures | ||||
| Acquisition of assets | ||||
| Land and mineral acquisition | ||||
| Acquisition of Maben assets (bond recovery in 2023) | ||||
| Maben Asset Acquisition | ||||
| Total acquisition of Maben assets (bond recovery in 2023) | ||||
| Proceeds from sale of mineral rights | ||||
| Insurance proceeds related to property, plant, and equipment | ||||
| Maben preparation plant capital expenditures | ||||
| Capitalized interest | ||||
| Payments to Acquire Property, Plant, and Equipment | ||||
| Other | ||||
| Net cash used in investing activities | ||||
| Cash flows from (used in) financing activities: | ||||
| Proceeds from issuance of senior note debt (net of $2,340 commissions and fees) | ||||
| Proceeds from equity offering | ||||
| Payment of equity offering costs | ||||
| Proceeds from long-term debt issuances | ||||
| Purchase of capped calls | ||||
| Proceeds from borrowings | ||||
| Repayment of borrowings | ||||
| Repayments of senior notes | ||||
| Repayment of Ramaco Coal acquisition financing - related party | ||||
| Proceeds from stock options exercised | ||||
| Payment of dividends | ||||
| Repayments of insurance financing | ||||
| Repayments of equipment finance leases | ||||
| Payment of debt issuance costs | ||||
| Shares surrendered for withholding taxes payable | ||||
| Net cash from (used in) financing activities | ||||
| Net change in cash and cash equivalents and restricted cash | ||||
| Cash and cash equivalents and restricted cash, beginning of period | ||||
| Cash and cash equivalents and restricted cash, end of period | ||||
| Cash and cash equivalents | ||||
| Restricted cash | ||||
| Total cash, cash equivalents and restricted cash | ||||
| Supplemental cash flow information: | ||||
| Cash paid for interest (net of amounts capitalized) | ||||
| Cash paid for income taxes | ||||
| Cash received for income tax refund | ||||
| Non-cash investing and financing activities: | ||||
| Leased assets under financing leases | ||||
| Capital expenditures included in accounts payable and accrued liabilities | ||||
| Financed insurance | ||||
| Financed insurance (2022 adjustment recorded in 2023) | ||||
| Accrued dividends and dividend equivalents payable | ||||
Loading...